Skip to main content
OpenTrials
Completed

NCT Number: NCT00812552

Drug Eluting Stent Registry of Thrombosis

Multicenter, case-control study, to collect data regarding incidences of late and very late drug-eluting stent thrombosis with the aim of identifying trends and possible correlates of stent thrombosis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Laval Hospital, Québec, Quebec, Canada

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients over 18 years of age
  • Case Subjects: patients who have experienced definite late or very late drug-eluting stent thrombosis
  • Control Subjects: patients who underwent drug-eluting stent implantation at the same facility and in the same time period as a matched Case Subject, and have not experienced drug-eluting stent thrombosis.

Exclusion criteria

  • Patients not meeting the above Inclusion Criteria

Treatment and study plan

Primary outcomes

  1. To assess for potential correlates surrounding subjects and lesions among patients that experience late or very late drug-eluting stent thrombosis

    Time frame: Baseline

Sponsors and collaborators

Lead sponsor

Medstar Health Research Institute

Other

Registry information

Acronym: DESERT

Important dates

Study start
2009
Primary completion
2012
Study completion
2012
First posted
Dec 22, 2008
Registry last updated
Apr 23, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.